BioSpace News Archive

Biotech Beach

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on August 10, 2023

Regen BioPharma, Inc., a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on August 10, 2023.

August 8, 2023
·
3 min read
Drug Development

Imvax Announces Publication in Journal for ImmunoTherapy of Cancer Showing IGV-001 Can Induce Clinically Relevant Anti-Cancer Immune Responses in Glioblastoma via Immunogenic Cell Death

Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today announced the publication of preclinical research with IGV-001 in Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC).

August 8, 2023
·
3 min read
BioMidwest

INVO Bioscience Announces Closing of $4.5 Million Public Offering

INVO Bioscience, Inc. announced the closing of its public offering of 1,580,000 units, with each unit consisting of one share of common stock and two warrants, each to purchase one share of common stock.

August 8, 2023
·
4 min read
Business

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

ThermoGenesis Holdings, Inc. announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.

August 8, 2023
·
3 min read
Business

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, reported financial and operating results for the second quarter and first half of 2023.

August 8, 2023
·
10 min read
Business

23andMe Reports FY2024 First Quarter Financial Results

23andMe Holding Co., a leading human genetics and biopharmaceutical company, reported its financial results for the first quarter of fiscal year 2024, which ended June 30, 2023.

August 8, 2023
·
18 min read
Business

Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

Fate Therapeutics, Inc. reported business highlights and financial results for the second quarter ended June 30, 2023.

August 8, 2023
·
13 min read
Business

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023

Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today reported financial results and business highlights for the second quarter ended June 30, 2023.

August 8, 2023
·
15 min read
Business

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results

Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the second quarter ended June 30, 2023.

August 8, 2023
·
15 min read
Business

Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the second quarter ended June 30, 2023.

August 8, 2023
·
18 min read